HomeAI · summaries
Storia in 5 fonti
To Wall Street, psychedelics biotechs are more teammates than rivals
Some analysts argue that, even for competitors, a big clinical trial win for Definium Therapeutics helps validate the psychedelic field and “bring it even further into the mainstream.”
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
zerohedge.com
Psychedelic Stocks Could Explode Higher
Positive clinical data is starting to trickle in and Trump wants to fast-track the sector...
- ·
statnews.com
Definium LSD therapy helped patients with major depression in late-stage trial
Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.
- ·
investors.com
Biotech Goes Sky-High After LSD Drug Treats Depression
One analyst called this a "best-case" scenario for the company's experimental depression treatment.
- ·
biopharmadive.com
To Wall Street, psychedelics biotechs are more teammates than rivals
Some analysts argue that, even for competitors, a big clinical trial win for Definium Therapeutics helps validate the psychedelic field and “bring it even further into the…
- ·
jpost.com
Wall Street investors rush into psychedelic drugs | The Jerusalem Post
Clinical trials prove the efficacy of psychedelic treatments. Dr. Itamar Cohen reveals the cold economic interest behind the establishment's legitimization.